PSMA6 and Hypertension: Thus, alpha-1 blockers, although originally developed for the treatment of arterial hypertension, have become the first line of pharmacologic management for lower urinary tract symptoms in men with benign prostatic hyperplasia (LUTS-BPH) [11–13].